ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 683856 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 683856; 2) Community: the network communities that were significantly associated with the response to NSC 683856; 3) Molecule: the relationships between components within communities and NSC 683856; 4) MDR: the compounds that were significantly associated with the NSC 683856.

NSC Compound Enrichment Correlation
NSC 733348 3-(4-Chlorobenzoyloxy)-7-(2-trifluoromethylphenyl)-1-hydroxy -2,4,8,9-tetrakis(methoxycarbonyl)bicyclo[3.3.1]non-3-ene 0.00957309511256283 0.12638275
NSC 749151 Null 0.00957309511256283 0.27211556
NSC 166382 Null 0.0105244982742819 0.090653382
NSC 300289 Pinafide 0.0105244982742819 0.3142898
NSC 351521 Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) 0.0105244982742819 -0.02231442
NSC 615534 Null 0.0105244982742819 0.1493296
NSC 681641 Camptothecin Derivative 0.0105244982742819 0.18457781
NSC 683556 Camptothecin Derivative 0.0105244982742819 0.1548768
NSC 700363 Liposomal Annamycin 0.0105244982742821 0.25027389
NSC 701743 Null 0.0105244982742821 0.17139499
Total:59  Current:12    [First] [Prev] [Next] [Last]